Encompass Health (NYSE:EHC) Price Target Raised to $95.00

Encompass Health (NYSE:EHC) had its price objective upped by research analysts at Mizuho from $93.00 to $95.00 in a research note issued to investors on Thursday, Benzinga reports. The firm currently has a “buy” rating on the stock. Mizuho’s price target would indicate a potential upside of 15.21% from the stock’s current price.

A number of other analysts have also commented on the company. Royal Bank of Canada restated an “outperform” rating and issued a $83.00 price target on shares of Encompass Health in a report on Friday, February 9th. Barclays lifted their target price on Encompass Health from $95.00 to $101.00 and gave the company an “overweight” rating in a research report on Thursday, March 28th. Stephens reaffirmed an “overweight” rating and issued a $85.00 target price on shares of Encompass Health in a research report on Tuesday, January 16th. Truist Financial lifted their target price on Encompass Health from $82.00 to $86.00 and gave the company a “buy” rating in a research report on Friday, February 9th. Finally, William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a research report on Wednesday, February 7th. Eight analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $86.56.

Encompass Health Stock Performance

Shares of Encompass Health stock opened at $82.46 on Thursday. The firm has a market cap of $8.26 billion, a price-to-earnings ratio of 22.29, a price-to-earnings-growth ratio of 1.53 and a beta of 0.94. The stock’s 50-day moving average is $78.25 and its 200-day moving average is $70.87. Encompass Health has a one year low of $57.55 and a one year high of $85.84. The company has a debt-to-equity ratio of 1.19, a current ratio of 1.28 and a quick ratio of 1.28.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Wednesday, April 24th. The company reported $1.12 EPS for the quarter, beating analysts’ consensus estimates of $0.93 by $0.19. The company had revenue of $1.32 billion for the quarter, compared to analyst estimates of $1.27 billion. Encompass Health had a return on equity of 18.48% and a net margin of 7.60%. The company’s quarterly revenue was up 13.4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.88 earnings per share. Equities analysts predict that Encompass Health will post 3.96 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Encompass Health

Institutional investors have recently bought and sold shares of the business. International Assets Investment Management LLC acquired a new position in Encompass Health during the fourth quarter worth approximately $20,210,000. Sumitomo Mitsui Trust Holdings Inc. grew its position in shares of Encompass Health by 2.3% in the fourth quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 1,318,784 shares of the company’s stock valued at $87,989,000 after purchasing an additional 29,926 shares during the last quarter. Phocas Financial Corp. grew its position in shares of Encompass Health by 112.4% in the fourth quarter. Phocas Financial Corp. now owns 99,875 shares of the company’s stock valued at $6,664,000 after purchasing an additional 52,847 shares during the last quarter. Nordea Investment Management AB grew its position in shares of Encompass Health by 21.0% in the fourth quarter. Nordea Investment Management AB now owns 101,705 shares of the company’s stock valued at $6,787,000 after purchasing an additional 17,684 shares during the last quarter. Finally, Oak Thistle LLC grew its position in shares of Encompass Health by 19.1% in the fourth quarter. Oak Thistle LLC now owns 14,436 shares of the company’s stock valued at $963,000 after purchasing an additional 2,319 shares during the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.